NCT05057351

A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic Dermatitis

Randomized, Double Blind, Clinical Study for Evaluating the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic Dermatitis. Controlled Study vs Placebo

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 44 (actual)
• Sponsor: Greenpharma S.A.S. · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Evaluation of safety and clinical efficacy of an active ingredient versus placebo for the treatment of mild to moderate Atopic Dermatitis (AD) adults.

Conditions

• Mild to Moderate Atopic Dermatitis

Interventions

Type	Name	Description
OTHER	Isopentenyltheophylline 0.44% + Glycerin 4.56%	Application of topical cream twice a day on the area affected by Atopic Dermatitis
OTHER	Glycerin 4.56%	Application of topical cream twice a day on the area affected by Atopic Dermatitis

Timeline

• Start date: 2020-09-01
• Primary completion: 2020-11-30
• Completion: 2021-03-31
• First posted: 2021-09-27
• Last updated: 2021-09-27

Locations

1 site across 1 country: Italy